1. Home
  2. KTCC vs IXHL Comparison

KTCC vs IXHL Comparison

Compare KTCC & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

HOLD

Current Price

$2.33

Market Cap

41.5M

Sector

Technology

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.64

Market Cap

39.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTCC
IXHL
Founded
1969
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Electrical Products
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
41.5M
39.0M
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
KTCC
IXHL
Price
$2.33
$3.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.0K
84.8K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,871,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$0.16
52 Week High
$4.42
$6.39

Technical Indicators

Market Signals
Indicator
KTCC
IXHL
Relative Strength Index (RSI) 23.77 58.16
Support Level $2.36 $3.10
Resistance Level $2.95 $3.68
Average True Range (ATR) 0.12 0.21
MACD 0.01 0.03
Stochastic Oscillator 13.54 71.85

Price Performance

Historical Comparison
KTCC
IXHL

About KTCC Key Tronic Corporation

Key Tronic Corporation provides electronic manufacturing services, including engineering, materials management, manufacturing and assembly, in-house testing, and distribution to various countries. The company serves diverse industries such as pest control, personal protection, air purification, automotive, medical technology, and utilities inspection equipment. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly. Key Tronic operates manufacturing facilities in the United States, Vietnam, and Mexico, recently expanding with a new facility in Arkansas. Revenue is generated mainly through contract manufacturing and service agreement.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: